Department of Experimental,
Diagnostic and Specialty Medicine - DIMES,
Department of Experimental, Diagnostic and Specialty Medicine - DIMES
Manuela Ferracin has not added Biography.
If you are Manuela Ferracin and would like to personalize this page please email our Author Liaison for assistance.
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.
Proceedings of the National Academy of Sciences of the United States of America Jun, 2004 | Pubmed ID: 15210942
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2004 | Pubmed ID: 15284443
Familial cancer associated with a polymorphism in ARLTS1.
The New England journal of medicine Apr, 2005 | Pubmed ID: 15843669
MicroRNA gene expression deregulation in human breast cancer.
Cancer research Aug, 2005 | Pubmed ID: 16103053
miR-15 and miR-16 induce apoptosis by targeting BCL2.
Proceedings of the National Academy of Sciences of the United States of America Sep, 2005 | Pubmed ID: 16166262
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
The New England journal of medicine Oct, 2005 | Pubmed ID: 16251535
A microRNA expression signature of human solid tumors defines cancer gene targets.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2006 | Pubmed ID: 16461460
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
Journal of cellular physiology Feb, 2007 | Pubmed ID: 17111382
A microRNA signature of hypoxia.
Molecular and cellular biology Mar, 2007 | Pubmed ID: 17194750
MicroRNAs in human cancer: from research to therapy.
Journal of cell science Jun, 2007 | Pubmed ID: 17515481
Regulation of microRNA expression: the hypoxic component.
Cell cycle (Georgetown, Tex.) Jun, 2007 | Pubmed ID: 17582223
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Cancer research Jul, 2007 | Pubmed ID: 17616664
Tumor suppressor functions of ARLTS1 in lung cancers.
Cancer research Aug, 2007 | Pubmed ID: 17699778
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer.
Molecular cancer , 2007 | Pubmed ID: 17716371
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.
Cancer cell Sep, 2007 | Pubmed ID: 17785203
Micro-RNA profiling in kidney and bladder cancers.
Urologic oncology Sep-Oct, 2007 | Pubmed ID: 17826655
MiR-15a and miR-16-1 cluster functions in human leukemia.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2008 | Pubmed ID: 18362358
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
Experimental hematology Aug, 2008 | Pubmed ID: 18504067
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation.
Free radical biology & medicine Jan, 2009 | Pubmed ID: 19022373
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
International journal of oncology Aug, 2009 | Pubmed ID: 19578755
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Cancer research Jul, 2009 | Pubmed ID: 19584283
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2009 | Pubmed ID: 19671867
Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
Blood Oct, 2009 | Pubmed ID: 19717645
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.
PloS one , 2009 | Pubmed ID: 19823581
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4.
BMC research notes , 2010 | Pubmed ID: 20181027
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment.
Leukemia research Oct, 2010 | Pubmed ID: 20227111
Modulation of mismatch repair and genomic stability by miR-155.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2010 | Pubmed ID: 20351277
Micromarkers: miRNAs in cancer diagnosis and prognosis.
Expert review of molecular diagnostics Apr, 2010 | Pubmed ID: 20370587
Oncogenic role of miR-483-3p at the IGF2/483 locus.
Cancer research Apr, 2010 | Pubmed ID: 20388800
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.
Molecular cancer , 2010 | Pubmed ID: 20504344
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.
Carcinogenesis Sep, 2010 | Pubmed ID: 20622002
Altered miRNA expression in T regulatory cells in course of multiple sclerosis.
Journal of neuroimmunology Sep, 2010 | Pubmed ID: 20637509
MicroRNAs dysregulation in human malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer May, 2011 | Pubmed ID: 21358347
Mutated beta-catenin evades a microRNA-dependent regulatory loop.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2011 | Pubmed ID: 21383185
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
The Journal of pathology Sep, 2011 | Pubmed ID: 21630269
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
The Journal of pathology Apr, 2012 | Pubmed ID: 21960059
MicroRNAs: toward the clinic for breast cancer patients.
Seminars in oncology Dec, 2011 | Pubmed ID: 22082762
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
Hepatology (Baltimore, Md.) Sep, 2012 | Pubmed ID: 22473819
miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.
PloS one , 2013 | Pubmed ID: 23437250
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.
Molecular medicine (Cambridge, Mass.) , 2013 | Pubmed ID: 23615966
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.
Frontiers in genetics , 2013 | Pubmed ID: 23630541
CCAT2, a novel non-coding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
Genome research Jun, 2013 | Pubmed ID: 23796952
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.
Haematologica Jan, 2014 | Pubmed ID: 23975180
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2013 | Pubmed ID: 24036852
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
PloS one , 2013 | Pubmed ID: 24066048
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
Molecular cancer , 2013 | Pubmed ID: 24165569
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.
Oncotarget Jan, 2014 | Pubmed ID: 24334759
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines.
Oncotarget Dec, 2013 | Pubmed ID: 24345856
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
Molecular cancer , 2013 | Pubmed ID: 24373626
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2014 | Pubmed ID: 24916701
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: a clinical and ultrasonographic study.
BioMed research international , 2014 | Pubmed ID: 25061602
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology.
PloS one , 2014 | Pubmed ID: 25148080
OncomiR detection in circulating body fluids: a PDMS microdevice perspective.
Lab on a chip Oct, 2014 | Pubmed ID: 25178053
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes.
Journal of cellular physiology Apr, 2015 | Pubmed ID: 25205602
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.
Thrombosis and haemostasis Mar, 2015 | Pubmed ID: 25374339
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis.
Stem cells (Dayton, Ohio) Mar, 2015 | Pubmed ID: 25428821
Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Dec, 2014 | Pubmed ID: 25472671
MicroRNAs as biomarker of Parkinson disease? Small but mighty.
Neurology Feb, 2015 | Pubmed ID: 25596504
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.
PloS one , 2015 | Pubmed ID: 25849663
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
Leukemia & lymphoma , 2015 | Pubmed ID: 25860243
Absolute quantification of cell-free microRNAs in cancer patients.
Oncotarget Jun, 2015 | Pubmed ID: 26036630
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
Biomarker research , 2015 | Pubmed ID: 26120471
Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.
Expert review of molecular diagnostics , 2015 | Pubmed ID: 26338209
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples.
Scientific reports , 2015 | Pubmed ID: 26382856
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Oncotarget Nov, 2015 | Pubmed ID: 26497852
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
PloS one , 2015 | Pubmed ID: 26509672
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Clinical epigenetics , 2015 | Pubmed ID: 26677401
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.
Cell reports Dec, 2015 | Pubmed ID: 26686630
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
Oncotarget Apr, 2016 | Pubmed ID: 27057640
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.
Oncotarget Apr, 2016 | Pubmed ID: 27120784
1Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna,
2Department of Morphology, Surgery and Experimental Medicine, University of Ferrara,
3Department of Life Sciences and Biotechnology, University of Ferrara,
4Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten